Gridai Technologies Corp. (GRDX) SEC Filings — 2025
32 SEC filings for Gridai Technologies Corp. (GRDX) in 2025.
Filings
- GridAI Technologies Corp. Files 8-K: Agreements, Officer Changes — 8-K · Dec 23, 2025
- GridAI Technologies Corp. Files 8-K with Key Corporate Updates — 8-K · Dec 4, 2025
- Entero Therapeutics Narrows Losses, Boosts Cash Amid Grid AI Acquisition — 10-Q · Nov 19, 2025
- Entero Therapeutics Files 8-K — 8-K · Nov 6, 2025
- Entero Therapeutics, Inc. 8-K Filing — 8-K · Oct 31, 2025
- Entero Therapeutics Enters Material Definitive Agreement — 8-K · Oct 22, 2025
- Entero Therapeutics Completes Acquisition, Discloses Equity Sales — 8-K · Oct 6, 2025
- Entero Therapeutics Files 8-K: Agreements, Officer Changes, Financials — 8-K · Sep 12, 2025
- Entero Therapeutics Faces Liquidity Crunch, Rescinds ImmunogenX Merger — S-1/A · Sep 10, 2025
- Entero Therapeutics Reports Agreement Termination & Officer Changes — 8-K · Sep 9, 2025
- Entero Therapeutics Narrows Focus to Adrulipase Amidst Merger Rescission, Cash Crunch — S-1 · Aug 26, 2025
- Entero Therapeutics Files 8-K on Security Holder Rights — 8-K · Aug 15, 2025
- Entero Therapeutics Narrows Losses, Faces Cash Crunch — 10-Q · Aug 14, 2025
- Entero Therapeutics Files 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Aug 11, 2025
- Entero Therapeutics Enters Material Definitive Agreement — 8-K · Jul 16, 2025
- Entero Therapeutics to Acquire 03 Life Sciences — 8-K · Jul 8, 2025
- Entero Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jul 2, 2025
- Entero Therapeutics Files 8-K for Unspecified Event — 8-K · Jun 30, 2025
- Entero Therapeutics Amends S-1, Signals Continuous Offering — S-1/A · Jun 23, 2025
- Entero Therapeutics Amends S-1/A for Continuous Offering — S-1/A · Jun 5, 2025
- Entero Therapeutics Sets Virtual Annual Meeting for June 30 — DEF 14A · Jun 4, 2025
- Entero Therapeutics Q1 2025: Assets Near Liabilities — 10-Q · May 15, 2025
- Entero Therapeutics Files 8-K on Agreements and Shareholder Nominations — 8-K · May 14, 2025
- Entero Therapeutics Files S-1 for Public Offering — S-1 · May 12, 2025
- Entero Therapeutics Faces Delisting Concerns — 8-K · Apr 14, 2025
- Entero Therapeutics Files 2024 10-K Amendment — 10-K/A · Apr 9, 2025
- Entero Therapeutics Files 2024 10-K — 10-K · Apr 1, 2025
- Entero Therapeutics Announces Material Agreement, Officer Changes — 8-K · Mar 25, 2025
- Entero Therapeutics Reports Delisting Notice & Officer Changes — 8-K · Mar 7, 2025
- Entero Therapeutics Announces Board and Compensation Changes — 8-K · Feb 14, 2025
- Entero Therapeutics Files 8-K: Agreements, Obligations, and Leadership Changes — 8-K · Feb 6, 2025
- Entero Therapeutics Faces Delisting Concerns — 8-K · Jan 13, 2025